Concepedia

Robert S. Kauffman

RS

46

Publications

10.5K

Citations

32

H-Index

1974

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Brigham and Women's Hospital

Harvard University

Cornell University

Goethe University Frankfurt

Robert S. Kauffman is an author at Vertex Pharmaceuticals (United States) specializing in medicine, immunology, and virology.

Top concepts

Publications per year

1974–2018

46

Publications

46

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

John G. McHutchison, Gregory T. Everson, Stuart C. Gordon et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2009 · 1K citations

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

Kenneth E. Sherman, Steven L. Flamm, Nezam H. Afdhal et al. · New England Journal of Medicine · 2011 · 744 citations · Full text

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

Kevin Fitzgerald, Suellen White, Anna Borodovsky et al. · New England Journal of Medicine · 2016 · 738 citations · Full text

Rows per page

1–5 of 46